• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Truncal acne following JAK inhibitor use in vitiligo with rare opportunistic fungal infections: Two case reports.

作者信息

Doh Jee Yun, Rintarhat Piyapat, Jung Won Hee, Kim Hei Sung

机构信息

Department of Dermatology, Seoul St. Mary`s Hospital, The Catholic University of Korea, Seoul, Republic of Korea.

Department of Systems Biotechnology, Chung-Ang University, Anseong, Republic of Korea.

出版信息

JAAD Case Rep. 2023 May 23;37:123-127. doi: 10.1016/j.jdcr.2023.05.018. eCollection 2023 Jul.

DOI:10.1016/j.jdcr.2023.05.018
PMID:37405176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10315772/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fed/10315772/7867068e1d7f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fed/10315772/f47f29279b9f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fed/10315772/7867068e1d7f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fed/10315772/f47f29279b9f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fed/10315772/7867068e1d7f/gr2.jpg

相似文献

1
Truncal acne following JAK inhibitor use in vitiligo with rare opportunistic fungal infections: Two case reports.白癜风患者使用JAK抑制剂后出现躯干痤疮并伴有罕见的机会性真菌感染：两例病例报告。
JAAD Case Rep. 2023 May 23;37:123-127. doi: 10.1016/j.jdcr.2023.05.018. eCollection 2023 Jul.
2
Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.使用Janus激酶抑制剂托法替布治疗白癜风时的色素再生可能需要同时暴露于光线下。
J Am Acad Dermatol. 2017 Oct;77(4):675-682.e1. doi: 10.1016/j.jaad.2017.05.043. Epub 2017 Aug 18.
3
Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient.外用托法替布：一种用于治疗青少年白癜风患者的Janus激酶抑制剂。
Case Rep Dermatol. 2021 Apr 1;13(1):190-194. doi: 10.1159/000513938. eCollection 2021 Jan-Apr.
4
The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature.Janus 激酶抑制剂在白癜风中的应用：文献综述。
J Cutan Med Surg. 2019 May/Jun;23(3):298-306. doi: 10.1177/1203475419833609. Epub 2019 Mar 22.
5
JAK-inhibitors in dermatology: current evidence and future applications.皮肤科中的 JAK 抑制剂：现有证据和未来应用。
J Dermatolog Treat. 2019 Nov;30(7):648-658. doi: 10.1080/09546634.2018.1546043. Epub 2018 Dec 3.
6
Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis.使用 Janus 激酶 (JAK) 抑制剂联合光疗治疗白癜风的复色作用：系统评价和 Meta 分析。
J Dermatolog Treat. 2022 Feb;33(1):173-177. doi: 10.1080/09546634.2020.1735615. Epub 2020 Apr 2.
7
Activation of Janus kinase signaling pathway in acne lesions.痤疮皮损中 Janus 激酶信号通路的激活。
Dermatol Ther. 2021 Jan;34(1):e14563. doi: 10.1111/dth.14563. Epub 2020 Nov 30.
8
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.Janus 激酶抑制剂治疗白癜风：综述。
Front Immunol. 2021 Nov 18;12:790125. doi: 10.3389/fimmu.2021.790125. eCollection 2021.
9
Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature.用于治疗皮肤和毛发疾病的Janus激酶（JAK）抑制剂：文献综述
J Dermatolog Treat. 2017 Sep;28(6):476-483. doi: 10.1080/09546634.2016.1277179. Epub 2017 Jan 22.
10
Cutaneous JAK Expression in Vitiligo.白癜风的皮肤 JAK 表达。
J Cutan Med Surg. 2021 Mar-Apr;25(2):157-162. doi: 10.1177/1203475420972340. Epub 2020 Nov 11.

本文引用的文献

1
A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis.特应性皮炎患者使用 Janus 激酶抑制剂后出现痤疮的病例系列报道。
JAAD Case Rep. 2022 Oct 11;30:11-16. doi: 10.1016/j.jdcr.2022.09.029. eCollection 2022 Dec.
2
Management of acne induced by JAK inhibitors.JAK抑制剂所致痤疮的管理
Dermatol Ther. 2022 Sep;35(9):e15688. doi: 10.1111/dth.15688. Epub 2022 Jul 19.
3
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
每日一次乌帕替尼对比安慰剂治疗中重度特应性皮炎青少年和成人患者（Measure Up1 和 Measure Up2）：两项复制性、双盲、随机对照 3 期临床试验结果。
Lancet. 2021 Jun 5;397(10290):2151-2168. doi: 10.1016/S0140-6736(21)00588-2. Epub 2021 May 21.
4
Analysis of Matched Skin and Gut Microbiome of Patients with Vitiligo Reveals Deep Skin Dysbiosis: Link with Mitochondrial and Immune Changes.分析白癜风患者的匹配皮肤和肠道微生物组揭示了深度皮肤失调：与线粒体和免疫变化的关联。
J Invest Dermatol. 2021 Sep;141(9):2280-2290. doi: 10.1016/j.jid.2021.01.036. Epub 2021 Mar 24.
5
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.阿泊替尼对比安慰剂或度普利尤单抗治疗特应性皮炎。
N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380.
6
Inferences in microbial structural signatures of acne microbiome and mycobiome.痤疮微生物组和真菌组的微生物结构特征的推论。
J Microbiol. 2021 Apr;59(4):369-375. doi: 10.1007/s12275-021-0647-1. Epub 2021 Feb 10.
7
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.巴瑞替尼联合外用皮质类固醇治疗中重度特应性皮炎的疗效和安全性：一项随机临床试验。
JAMA Dermatol. 2020 Dec 1;156(12):1333-1343. doi: 10.1001/jamadermatol.2020.3260.
8
as an emerging opportunistic pathogen: First case of superinfection in herpetic keratitis.作为一种新兴的机会性致病菌：疱疹性角膜炎继发感染的首例病例。
Am J Ophthalmol Case Rep. 2020 Jun 25;19:100791. doi: 10.1016/j.ajoc.2020.100791. eCollection 2020 Sep.
9
Mixed Infection of Toe Nail Caused by Trichosporon asahii and Rhodotorula mucilaginosa.申克孢子丝菌和粘红酵母混合感染趾甲
Mycopathologia. 2020 Apr;185(2):373-376. doi: 10.1007/s11046-019-00406-y. Epub 2019 Nov 23.
10
Geographical and Ethnic Differences Influence Culturable Commensal Yeast Diversity on Healthy Skin.地理和种族差异影响健康皮肤上可培养的共生酵母多样性。
Front Microbiol. 2019 Aug 27;10:1891. doi: 10.3389/fmicb.2019.01891. eCollection 2019.